ResultsBusiness Today
NATCO Pharma Q2 profit falls 61% to Rs 203 crore
GreyOak summary
NATCO Pharma reported a 61% year-on-year decline in consolidated net profit to Rs 203 crore for Q2 FY27, driven by a 30% drop in revenue. The company attributed the loss primarily to lower Lenalidomide revenue, partially offset by growth in its base business and international formulations.
What it affects
- Natco PharmaNATCOPHARMNegative -99
Profit fell 61% to Rs 203 croreRolling sentiment Negative -87
Source
Read the original at Business TodayMore Natco Pharma news
- Natco Pharma Q2 profit, revenue fall; dividend declaredCNBC-TV18 · Results ·
- Natco Pharma Q2 Profit Falls 61% to Rs 203 CrNDTV Profit · Results ·